Global Antimicrobial Peptides Market Insights and Forecast to 2031

Report ID: 844760 | Published Date: Jan 2025 | No. of Page: 119 | Base Year: 2024 | Rating: 4 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Antimicrobial Peptides Product Introduction
    1.2 Market by Type
        1.2.1 Global Antimicrobial Peptides Market Size Growth Rate by Type
        1.4.2 Plant Antimicrobial Peptides
        1.4.3 Microbial Antimicrobial Peptides
        1.2.4 Animal Antimicrobial Peptides
    1.3 Market by Application
        1.3.1 Global Antimicrobial Peptides Market Size Growth Rate by Application
        1.3.2 Pharmaceuticals
        1.3.3 Feed Additives
        1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
    2.1 Global Antimicrobial Peptides Sales Estimates and Forecasts 2016-2027
    2.2 Global Antimicrobial Peptides Revenue Estimates and Forecasts 2016-2027
    2.3 Global Antimicrobial Peptides Revenue by Region: 2016 VS 2021 VS 2027
    2.4 Global Top Antimicrobial Peptides Regions by Sales
        2.4.1 Global Top Antimicrobial Peptides Regions by Sales (2016-2021)
        2.4.2 Global Top Antimicrobial Peptides Regions by Sales (2022-2027)
    2.5 Global Top Antimicrobial Peptides Regions by Revenue
        2.5.1 Global Top Antimicrobial Peptides Regions by Revenue (2016-2021)
        2.5.2 Global Top Antimicrobial Peptides Regions by Revenue (2022-2027)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Antimicrobial Peptides Sales by Manufacturers
        3.1.1 Global Top Antimicrobial Peptides Manufacturers by Sales (2016-2021)
        3.1.2 Global Top Antimicrobial Peptides Manufacturers Market Share by Sales (2016-2021)
        3.1.3 Global Top 10 and Top 5 Companies by Antimicrobial Peptides Sales in 2020
    3.2 Global Antimicrobial Peptides Revenue by Manufacturers
        3.2.1 Global Top Antimicrobial Peptides Manufacturers by Revenue (2016-2021)
        3.2.2 Global Top Antimicrobial Peptides Manufacturers Market Share by Revenue (2016-2021)
        3.2.3 Global Top 10 and Top 5 Companies by Antimicrobial Peptides Revenue in 2020
    3.3 Global Antimicrobial Peptides Sales Price by Manufacturers
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Antimicrobial Peptides Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Antimicrobial Peptides Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
    4.1 Global Antimicrobial Peptides Sales by Type
        4.1.1 Global Antimicrobial Peptides Historical Sales by Type (2016-2021)
        4.1.2 Global Antimicrobial Peptides Forecasted Sales by Type (2022-2027)
        4.1.3 Global Antimicrobial Peptides Sales Market Share by Type (2016-2027)
    4.2 Global Antimicrobial Peptides Revenue by Type
        4.2.1 Global Antimicrobial Peptides Historical Revenue by Type (2016-2021)
        4.2.2 Global Antimicrobial Peptides Forecasted Revenue by Type (2022-2027)
        4.2.3 Global Antimicrobial Peptides Revenue Market Share by Type (2016-2027)
    4.3 Global Antimicrobial Peptides Price by Type
        4.3.1 Global Antimicrobial Peptides Price by Type (2016-2021)
        4.3.2 Global Antimicrobial Peptides Price Forecast by Type (2022-2027)
5 Market Size by Application
    5.1 Global Antimicrobial Peptides Sales by Application
        5.1.1 Global Antimicrobial Peptides Historical Sales by Application (2016-2021)
        5.1.2 Global Antimicrobial Peptides Forecasted Sales by Application (2022-2027)
        5.1.3 Global Antimicrobial Peptides Sales Market Share by Application (2016-2027)
    5.2 Global Antimicrobial Peptides Revenue by Application
        5.2.1 Global Antimicrobial Peptides Historical Revenue by Application (2016-2021)
        5.2.2 Global Antimicrobial Peptides Forecasted Revenue by Application (2022-2027)
        5.2.3 Global Antimicrobial Peptides Revenue Market Share by Application (2016-2027)
    5.3 Global Antimicrobial Peptides Price by Application
        5.3.1 Global Antimicrobial Peptides Price by Application (2016-2021)
        5.3.2 Global Antimicrobial Peptides Price Forecast by Application (2022-2027)

6 North America
    6.1 North America Antimicrobial Peptides Market Size by Type
        6.1.1 North America Antimicrobial Peptides Sales by Type (2016-2027)
        6.1.2 North America Antimicrobial Peptides Revenue by Type (2016-2027)
    6.2 North America Antimicrobial Peptides Market Size by Application
        6.2.1 North America Antimicrobial Peptides Sales by Application (2016-2027)
        6.2.2 North America Antimicrobial Peptides Revenue by Application (2016-2027)
    6.3 North America Antimicrobial Peptides Market Size by Country
        6.3.1 North America Antimicrobial Peptides Sales by Country (2016-2027)
        6.3.2 North America Antimicrobial Peptides Revenue by Country (2016-2027)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Antimicrobial Peptides Market Size by Type
        7.1.1 Europe Antimicrobial Peptides Sales by Type (2017-2027)
        7.1.2 Europe Antimicrobial Peptides Revenue by Type (2017-2027)
    7.2 Europe Antimicrobial Peptides Market Size by Application
        7.2.1 Europe Antimicrobial Peptides Sales by Application (2017-2027)
        7.2.2 Europe Antimicrobial Peptides Revenue by Application (2017-2027)
    7.3 Europe Antimicrobial Peptides Market Size by Country
        7.3.1 Europe Antimicrobial Peptides Sales by Country (2017-2027)
        7.3.2 Europe Antimicrobial Peptides Revenue by Country (2017-2027)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Antimicrobial Peptides Market Size by Type
        8.1.1 Asia Pacific Antimicrobial Peptides Sales by Type (2018-2027)
        8.1.2 Asia Pacific Antimicrobial Peptides Revenue by Type (2018-2027)
    8.2 Asia Pacific Antimicrobial Peptides Market Size by Application
        8.2.1 Asia Pacific Antimicrobial Peptides Sales by Application (2018-2027)
        8.2.2 Asia Pacific Antimicrobial Peptides Revenue by Application (2018-2027)
    8.3 Asia Pacific Antimicrobial Peptides Market Size by Region
        8.3.1 Asia Pacific Antimicrobial Peptides Sales by Region (2018-2027)
        8.3.2 Asia Pacific Antimicrobial Peptides Revenue by Region (2018-2027)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Antimicrobial Peptides Market Size by Type
        9.1.1 Latin America Antimicrobial Peptides Sales by Type (2019-2027)
        9.1.2 Latin America Antimicrobial Peptides Revenue by Type (2019-2027)
    9.2 Latin America Antimicrobial Peptides Market Size by Application
        9.2.1 Latin America Antimicrobial Peptides Sales by Application (2019-2027)
        9.2.2 Latin America Antimicrobial Peptides Revenue by Application (2019-2027)
    9.3 Latin America Antimicrobial Peptides Market Size by Country
        9.3.1 Latin America Antimicrobial Peptides Sales by Country (2019-2027)
        9.3.2 Latin America Antimicrobial Peptides Revenue by Country (2019-2027)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
6 Middle East and Africa
    6.1 Middle East and Africa Antimicrobial Peptides Market Size by Type
        6.1.1 Middle East and Africa Antimicrobial Peptides Sales by Type (2016-2027)
        6.1.2 Middle East and Africa Antimicrobial Peptides Revenue by Type (2016-2027)
    6.2 Middle East and Africa Antimicrobial Peptides Market Size by Application
        6.2.1 Middle East and Africa Antimicrobial Peptides Sales by Application (2016-2027)
        6.2.2 Middle East and Africa Antimicrobial Peptides Revenue by Application (2016-2027)
    6.3 Middle East and Africa Antimicrobial Peptides Market Size by Country
        6.3.1 Middle East and Africa Antimicrobial Peptides Sales by Country (2016-2027)
        6.3.2 Middle East and Africa Antimicrobial Peptides Revenue by Country (2016-2027)
        6.3.3 Turkey
        6.3.4 Saudi Arabia
        6.3.5 U.A.E

11 Company Profiles
    11.1 AnaSpec
        11.1.1 AnaSpec Corporation Information
        11.1.2 AnaSpec Overview
        11.1.3 AnaSpec Antimicrobial Peptides Sales, Price, Revenue and Gross Margin (2016-2021)
        11.1.4 AnaSpec Antimicrobial Peptides Product Description
        11.1.5 AnaSpec Related Developments
    11.2 AMP Biotech
        11.2.1 AMP Biotech Corporation Information
        11.2.2 AMP Biotech Overview
        11.2.3 AMP Biotech Antimicrobial Peptides Sales, Price, Revenue and Gross Margin (2016-2021)
        11.2.4 AMP Biotech Antimicrobial Peptides Product Description
        11.2.5 AMP Biotech Related Developments
    11.3 Phoenix Biotech
        11.3.1 Phoenix Biotech Corporation Information
        11.3.2 Phoenix Biotech Overview
        11.3.3 Phoenix Biotech Antimicrobial Peptides Sales, Price, Revenue and Gross Margin (2016-2021)
        11.3.4 Phoenix Biotech Antimicrobial Peptides Product Description
        11.3.5 Phoenix Biotech Related Developments
    11.4 Novabiotics
        11.4.1 Novabiotics Corporation Information
        11.4.2 Novabiotics Overview
        11.4.3 Novabiotics Antimicrobial Peptides Sales, Price, Revenue and Gross Margin (2016-2021)
        11.4.4 Novabiotics Antimicrobial Peptides Product Description
        11.4.5 Novabiotics Related Developments
    11.5 Chinese Peptide
        11.5.1 Chinese Peptide Corporation Information
        11.5.2 Chinese Peptide Overview
        11.5.3 Chinese Peptide Antimicrobial Peptides Sales, Price, Revenue and Gross Margin (2016-2021)
        11.5.4 Chinese Peptide Antimicrobial Peptides Product Description
        11.5.5 Chinese Peptide Related Developments
    11.6 Ontores
        11.6.1 Ontores Corporation Information
        11.6.2 Ontores Overview
        11.6.3 Ontores Antimicrobial Peptides Sales, Price, Revenue and Gross Margin (2016-2021)
        11.6.4 Ontores Antimicrobial Peptides Product Description
        11.6.5 Ontores Related Developments
    11.7 GenScript
        11.7.1 GenScript Corporation Information
        11.7.2 GenScript Overview
        11.7.3 GenScript Antimicrobial Peptides Sales, Price, Revenue and Gross Margin (2016-2021)
        11.7.4 GenScript Antimicrobial Peptides Product Description
        11.7.5 GenScript Related Developments
    11.8 Hycult Biotech
        11.8.1 Hycult Biotech Corporation Information
        11.8.2 Hycult Biotech Overview
        11.8.3 Hycult Biotech Antimicrobial Peptides Sales, Price, Revenue and Gross Margin (2016-2021)
        11.8.4 Hycult Biotech Antimicrobial Peptides Product Description
        11.8.5 Hycult Biotech Related Developments
    11.9 Sunsmile
        11.9.1 Sunsmile Corporation Information
        11.9.2 Sunsmile Overview
        11.9.3 Sunsmile Antimicrobial Peptides Sales, Price, Revenue and Gross Margin (2016-2021)
        11.9.4 Sunsmile Antimicrobial Peptides Product Description
        11.9.5 Sunsmile Related Developments
    11.10 Ruixing Biotechnology
        11.10.1 Ruixing Biotechnology Corporation Information
        11.10.2 Ruixing Biotechnology Overview
        11.10.3 Ruixing Biotechnology Antimicrobial Peptides Sales, Price, Revenue and Gross Margin (2016-2021)
        11.10.4 Ruixing Biotechnology Antimicrobial Peptides Product Description
        11.10.5 Ruixing Biotechnology Related Developments
    11.1 AnaSpec
        11.1.1 AnaSpec Corporation Information
        11.1.2 AnaSpec Overview
        11.1.3 AnaSpec Antimicrobial Peptides Sales, Price, Revenue and Gross Margin (2016-2021)
        11.1.4 AnaSpec Antimicrobial Peptides Product Description
        11.1.5 AnaSpec Related Developments
    11.12 Glam Technology
        11.12.1 Glam Technology Corporation Information
        11.12.2 Glam Technology Overview
        11.12.3 Glam Technology Antimicrobial Peptides Sales, Price, Revenue and Gross Margin (2016-2021)
        11.12.4 Glam Technology Product Description
        11.12.5 Glam Technology Related Developments
    11.13 ProteLight Pharmaceutical & Biotechnology
        11.13.1 ProteLight Pharmaceutical & Biotechnology Corporation Information
        11.13.2 ProteLight Pharmaceutical & Biotechnology Overview
        11.13.3 ProteLight Pharmaceutical & Biotechnology Antimicrobial Peptides Sales, Price, Revenue and Gross Margin (2016-2021)
        11.13.4 ProteLight Pharmaceutical & Biotechnology Product Description
        11.13.5 ProteLight Pharmaceutical & Biotechnology Related Developments

12 Value Chain and Sales Channels Analysis
    12.1 Antimicrobial Peptides Value Chain Analysis
    12.2 Antimicrobial Peptides Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Antimicrobial Peptides Production Mode & Process
    12.4 Antimicrobial Peptides Sales and Marketing
        12.4.1 Antimicrobial Peptides Sales Channels
        12.4.2 Antimicrobial Peptides Distributors
    12.5 Antimicrobial Peptides Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Antimicrobial Peptides Industry Trends
    13.2 Antimicrobial Peptides Market Drivers
    13.3 Antimicrobial Peptides Market Challenges
    13.4 Antimicrobial Peptides Market Restraints

14 Key Findings in The Global Antimicrobial Peptides Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer
List of Tables
    Table 1. Global Antimicrobial Peptides Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
    Table 2. Major Manufacturers of Plant Antimicrobial Peptides
    Table 3. Major Manufacturers of Microbial Antimicrobial Peptides
    Table 4. Major Manufacturers of Animal Antimicrobial Peptides
    Table 5. Global Antimicrobial Peptides Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million)
    Table 6. Global Antimicrobial Peptides Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million)
    Table 7. Global Antimicrobial Peptides Sales by Region (2016-2021) & (Mg)
    Table 8. Global Antimicrobial Peptides Sales Market Share by Region (2016-2021)
    Table 9. Global Antimicrobial Peptides Sales by Region (2016-2021) & (Mg)
    Table 10. Global Antimicrobial Peptides Sales Market Share by Region (2022-2027)
    Table 11. Global Antimicrobial Peptides Revenue by Region (2016-2021) & (US$ Million)
    Table 12. Global Antimicrobial Peptides Revenue Market Share by Region (2016-2021)
    Table 13. Global Antimicrobial Peptides Revenue by Region (2022-2027) & (US$ Million)
    Table 14. Global Antimicrobial Peptides Revenue Market Share by Region (2022-2027)
    Table 15. Global Antimicrobial Peptides Sales by Manufacturers (2016-2021) & (Mg)
    Table 16. Global Antimicrobial Peptides Sales Share by Manufacturers (2016-2021)
    Table 17. Global Antimicrobial Peptides Revenue by Manufacturers (2016-2021) & (US$ Million)
    Table 18. Global Antimicrobial Peptides Revenue Share by Manufacturers (2016-2021)
    Table 19. Antimicrobial Peptides Price by Manufacturers 2016-2021 (US$/Mg)
    Table 20. Global Antimicrobial Peptides Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 21. Global Antimicrobial Peptides by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antimicrobial Peptides as of 2020)
    Table 22. Antimicrobial Peptides Manufacturing Base Distribution and Headquarters
    Table 23. Manufacturers Antimicrobial Peptides Product Offered
    Table 24. Date of Manufacturers Enter into Antimicrobial Peptides Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Antimicrobial Peptides Sales by Type (2016-2021) & (Mg)
    Table 27. Global Antimicrobial Peptides Sales by Type (2022-2027) & (Mg)
    Table 28. Global Antimicrobial Peptides Sales Share by Type (2016-2021)
    Table 29. Global Antimicrobial Peptides Sales Share by Type (2022-2027)
    Table 30. Global Antimicrobial Peptides Revenue by Type (2016-2021) & (US$ Million)
    Table 31. Global Antimicrobial Peptides Revenue by Type (2022-2027) & (US$ Million)
    Table 32. Global Antimicrobial Peptides Revenue Share by Type (2016-2021)
    Table 33. Global Antimicrobial Peptides Revenue Share by Type (2022-2027)
    Table 34. Antimicrobial Peptides Price by Type (2016-2021) & (US$/Mg)
    Table 35. Global Antimicrobial Peptides Price Forecast by Type (2022-2027) & (US$/Mg)
    Table 36. Global Antimicrobial Peptides Sales by Application (2016-2021) & (Mg)
    Table 37. Global Antimicrobial Peptides Sales by Application (2022-2027) & (Mg)
    Table 38. Global Antimicrobial Peptides Sales Share by Application (2016-2021)
    Table 39. Global Antimicrobial Peptides Sales Share by Application (2022-2027)
    Table 40. Global Antimicrobial Peptides Revenue by Application (2016-2021) & (US$ Million)
    Table 41. Global Antimicrobial Peptides Revenue by Application (2022-2027) & (US$ Million)
    Table 42. Global Antimicrobial Peptides Revenue Share by Application (2016-2021)
    Table 43. Global Antimicrobial Peptides Revenue Share by Application (2022-2027)
    Table 44. Antimicrobial Peptides Price by Application (2016-2021) & (US$/Mg)
    Table 45. Global Antimicrobial Peptides Price Forecast by Application (2022-2027) & (US$/Mg)
    Table 46. North America Antimicrobial Peptides Sales by Type (2016-2021) & (Mg)
    Table 47. North America Antimicrobial Peptides Sales by Type (2022-2027) & (Mg)
    Table 48. North America Antimicrobial Peptides Revenue by Type (2016-2021) & (US$ Million)
    Table 49. North America Antimicrobial Peptides Revenue by Type (2022-2027) & (US$ Million)
    Table 50. North America Antimicrobial Peptides Sales by Application (2016-2021) & (Mg)
    Table 51. North America Antimicrobial Peptides Sales by Application (2022-2027) & (Mg)
    Table 52. North America Antimicrobial Peptides Revenue by Application (2016-2021) & (US$ Million)
    Table 53. North America Antimicrobial Peptides Revenue by Application (2022-2027) & (US$ Million)
    Table 54. North America Antimicrobial Peptides Sales by Country (2016-2021) & (Mg)
    Table 55. North America Antimicrobial Peptides Sales by Country (2022-2027) & (Mg)
    Table 56. North America Antimicrobial Peptides Revenue by Country (2016-2021) & (US$ Million)
    Table 57. North America Antimicrobial Peptides Revenue by Country (2022-2027) & (US$ Million)
    Table 58. Europe Antimicrobial Peptides Sales by Type (2016-2021) & (Mg)
    Table 59. Europe Antimicrobial Peptides Sales by Type (2022-2027) & (Mg)
    Table 60. Europe Antimicrobial Peptides Revenue by Type (2016-2021) & (US$ Million)
    Table 61. Europe Antimicrobial Peptides Revenue by Type (2022-2027) & (US$ Million)
    Table 62. Europe Antimicrobial Peptides Sales by Application (2016-2021) & (Mg)
    Table 63. Europe Antimicrobial Peptides Sales by Application (2022-2027) & (Mg)
    Table 64. Europe Antimicrobial Peptides Revenue by Application (2016-2021) & (US$ Million)
    Table 65. Europe Antimicrobial Peptides Revenue by Application (2022-2027) & (US$ Million)
    Table 66. Europe Antimicrobial Peptides Sales by Country (2016-2021) & (Mg)
    Table 67. Europe Antimicrobial Peptides Sales by Country (2022-2027) & (Mg)
    Table 68. Europe Antimicrobial Peptides Revenue by Country (2016-2021) & (US$ Million)
    Table 69. Europe Antimicrobial Peptides Revenue by Country (2022-2027) & (US$ Million)
    Table 70. Asia Pacific Antimicrobial Peptides Sales by Type (2016-2021) & (Mg)
    Table 71. Asia Pacific Antimicrobial Peptides Sales by Type (2022-2027) & (Mg)
    Table 72. Asia Pacific Antimicrobial Peptides Revenue by Type (2016-2021) & (US$ Million)
    Table 73. Asia Pacific Antimicrobial Peptides Revenue by Type (2022-2027) & (US$ Million)
    Table 74. Asia Pacific Antimicrobial Peptides Sales by Application (2016-2021) & (Mg)
    Table 75. Asia Pacific Antimicrobial Peptides Sales by Application (2022-2027) & (Mg)
    Table 76. Asia Pacific Antimicrobial Peptides Revenue by Application (2016-2021) & (US$ Million)
    Table 77. Asia Pacific Antimicrobial Peptides Revenue by Application (2022-2027) & (US$ Million)
    Table 78. Asia Pacific Antimicrobial Peptides Sales by Region (2016-2021) & (Mg)
    Table 79. Asia Pacific Antimicrobial Peptides Sales by Region (2022-2027) & (Mg)
    Table 80. Asia Pacific Antimicrobial Peptides Revenue by Region (2016-2021) & (US$ Million)
    Table 81. Asia Pacific Antimicrobial Peptides Revenue by Region (2022-2027) & (US$ Million)
    Table 82. Latin America Antimicrobial Peptides Sales by Type (2016-2021) & (Mg)
    Table 83. Latin America Antimicrobial Peptides Sales by Type (2022-2027) & (Mg)
    Table 84. Latin America Antimicrobial Peptides Revenue by Type (2016-2021) & (US$ Million)
    Table 85. Latin America Antimicrobial Peptides Revenue by Type (2022-2027) & (US$ Million)
    Table 86. Latin America Antimicrobial Peptides Sales by Application (2016-2021) & (Mg)
    Table 87. Latin America Antimicrobial Peptides Sales by Application (2022-2027) & (Mg)
    Table 88. Latin America Antimicrobial Peptides Revenue by Application (2016-2021) & (US$ Million)
    Table 89. Latin America Antimicrobial Peptides Revenue by Application (2022-2027) & (US$ Million)
    Table 90. Latin America Antimicrobial Peptides Sales by Country (2016-2021) & (Mg)
    Table 91. Latin America Antimicrobial Peptides Sales by Country (2022-2027) & (Mg)
    Table 92. Latin America Antimicrobial Peptides Revenue by Country (2016-2021) & (US$ Million)
    Table 93. Latin America Antimicrobial Peptides Revenue by Country (2022-2027) & (US$ Million)
    Table 94. Middle East and Africa Antimicrobial Peptides Sales by Type (2016-2021) & (Mg)
    Table 95. Middle East and Africa Antimicrobial Peptides Sales by Type (2022-2027) & (Mg)
    Table 96. Middle East and Africa Antimicrobial Peptides Revenue by Type (2016-2021) & (US$ Million)
    Table 97. Middle East and Africa Antimicrobial Peptides Revenue by Type (2022-2027) & (US$ Million)
    Table 98. Middle East and Africa Antimicrobial Peptides Sales by Application (2016-2021) & (Mg)
    Table 99. Middle East and Africa Antimicrobial Peptides Sales by Application (2022-2027) & (Mg)
    Table 100. Middle East and Africa Antimicrobial Peptides Revenue by Application (2016-2021) & (US$ Million)
    Table 101. Middle East and Africa Antimicrobial Peptides Revenue by Application (2022-2027) & (US$ Million)
    Table 102. Middle East and Africa Antimicrobial Peptides Sales by Country (2016-2021) & (Mg)
    Table 103. Middle East and Africa Antimicrobial Peptides Sales by Country (2022-2027) & (Mg)
    Table 104. Middle East and Africa Antimicrobial Peptides Revenue by Country (2016-2021) & (US$ Million)
    Table 105. Middle East and Africa Antimicrobial Peptides Revenue by Country (2022-2027) & (US$ Million)
    Table 106. AnaSpec Corporation Information
    Table 107. AnaSpec Description and Major Businesses
    Table 108. AnaSpec Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2016-2021)
    Table 109. AnaSpec Antimicrobial Peptides Product
    Table 110. AnaSpec Recent Developments
    Table 111. AMP Biotech Corporation Information
    Table 112. AMP Biotech Description and Major Businesses
    Table 113. AMP Biotech Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2016-2021)
    Table 114. AMP Biotech Antimicrobial Peptides Product
    Table 115. AMP Biotech Recent Developments
    Table 116. Phoenix Biotech Corporation Information
    Table 117. Phoenix Biotech Description and Major Businesses
    Table 118. Phoenix Biotech Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2016-2021)
    Table 119. Phoenix Biotech Antimicrobial Peptides Product
    Table 120. Phoenix Biotech Recent Developments
    Table 121. Novabiotics Corporation Information
    Table 122. Novabiotics Description and Major Businesses
    Table 123. Novabiotics Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2016-2021)
    Table 124. Novabiotics Antimicrobial Peptides Product
    Table 125. Novabiotics Recent Developments
    Table 126. Chinese Peptide Corporation Information
    Table 127. Chinese Peptide Description and Major Businesses
    Table 128. Chinese Peptide Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2016-2021)
    Table 129. Chinese Peptide Antimicrobial Peptides Product
    Table 130. Chinese Peptide Recent Developments
    Table 131. Ontores Corporation Information
    Table 132. Ontores Description and Major Businesses
    Table 133. Ontores Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2016-2021)
    Table 134. Ontores Antimicrobial Peptides Product
    Table 135. Ontores Recent Developments
    Table 136. GenScript Corporation Information
    Table 137. GenScript Description and Major Businesses
    Table 138. GenScript Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2016-2021)
    Table 139. GenScript Antimicrobial Peptides Product
    Table 140. GenScript Recent Developments
    Table 141. Hycult Biotech Corporation Information
    Table 142. Hycult Biotech Description and Major Businesses
    Table 143. Hycult Biotech Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2016-2021)
    Table 144. Hycult Biotech Antimicrobial Peptides Product
    Table 145. Hycult Biotech Recent Developments
    Table 146. Sunsmile Corporation Information
    Table 147. Sunsmile Description and Major Businesses
    Table 148. Sunsmile Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2016-2021)
    Table 149. Sunsmile Antimicrobial Peptides Product
    Table 150. Sunsmile Recent Developments
    Table 151. Ruixing Biotechnology Corporation Information
    Table 152. Ruixing Biotechnology Description and Major Businesses
    Table 153. Ruixing Biotechnology Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2016-2021)
    Table 154. Ruixing Biotechnology Antimicrobial Peptides Product
    Table 155. Ruixing Biotechnology Recent Developments
    Table 156. Zhongnong Yingtai Biotechnology Corporation Information
    Table 157. Zhongnong Yingtai Biotechnology Description and Major Businesses
    Table 158. Zhongnong Yingtai Biotechnology Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2016-2021)
    Table 159. Zhongnong Yingtai Biotechnology Antimicrobial Peptides Product
    Table 160. Zhongnong Yingtai Biotechnology Recent Developments
    Table 161. Glam Technology Corporation Information
    Table 162. Glam Technology Description and Major Businesses
    Table 163. Glam Technology Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2016-2021)
    Table 164. Glam Technology Antimicrobial Peptides Product
    Table 165. Glam Technology Recent Developments
    Table 166. ProteLight Pharmaceutical & Biotechnology Corporation Information
    Table 167. ProteLight Pharmaceutical & Biotechnology Description and Major Businesses
    Table 168. ProteLight Pharmaceutical & Biotechnology Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2016-2021)
    Table 169. ProteLight Pharmaceutical & Biotechnology Antimicrobial Peptides Product
    Table 170. ProteLight Pharmaceutical & Biotechnology Recent Developments
    Table 171. Key Raw Materials Lists
    Table 172. Raw Materials Key Suppliers Lists
    Table 173. Antimicrobial Peptides Distributors List
    Table 174. Antimicrobial Peptides Customers List
    Table 175. Antimicrobial Peptides Market Trends
    Table 176. Antimicrobial Peptides Market Drivers
    Table 177. Antimicrobial Peptides Market Challenges
    Table 178. Antimicrobial Peptides Market Restraints
    Table 179. Research Programs/Design for This Report
    Table 180. Key Data Information from Secondary Sources
    Table 181. Key Data Information from Primary Sources
List of Figures
    Figure 1. Antimicrobial Peptides Product Picture
    Figure 2. Global Antimicrobial Peptides Market Share by Type in 2020 & 2027
    Figure 3. Plant Antimicrobial Peptides Product Picture
    Figure 4. Microbial Antimicrobial Peptides Product Picture
    Figure 5. Animal Antimicrobial Peptides Product Picture
    Figure 6. Global Antimicrobial Peptides Sales Market Share by Application in 2020 & 2027
    Figure 7. Pharmaceuticals
    Figure 8. Feed Additives
    Figure 9. Others
    Figure 10. Antimicrobial Peptides Report Years Considered
    Figure 11. Global Antimicrobial Peptides Sales 2016-2027 (Mg)
    Figure 12. Global Antimicrobial Peptides Revenue, (US$ Million), 2016 VS 2021 VS 2027
    Figure 13. Global Antimicrobial Peptides Revenue 2016-2027 (US$ Million)
    Figure 14. Global Antimicrobial Peptides Revenue Market Share by Region in Percentage: 2020 Versus 2027
    Figure 15. Global Antimicrobial Peptides Sales Market Share by Region (2016-2021)
    Figure 16. Global Antimicrobial Peptides Sales Market Share by Region (2022-2027)
    Figure 17. North America Antimicrobial Peptides Sales YoY (2016-2027) & (Mg)
    Figure 18. North America Antimicrobial Peptides Revenue YoY (2016-2027) & (US$ Million)
    Figure 19. Europe Antimicrobial Peptides Sales YoY (2016-2027) & (Mg)
    Figure 20. Europe Antimicrobial Peptides Revenue YoY (2016-2027) & (US$ Million)
    Figure 21. Asia-Pacific Antimicrobial Peptides Sales YoY (2016-2027) & (Mg)
    Figure 22. Asia-Pacific Antimicrobial Peptides Revenue YoY (2016-2027) & (US$ Million)
    Figure 23. Latin America Antimicrobial Peptides Sales YoY (2016-2027) & (Mg)
    Figure 24. Latin America Antimicrobial Peptides Revenue YoY (2016-2027) & (US$ Million)
    Figure 25. Middle East & Africa Antimicrobial Peptides Sales YoY (2016-2027) & (Mg)
    Figure 26. Middle East & Africa Antimicrobial Peptides Revenue YoY (2016-2027) & (US$ Million)
    Figure 27. The Top 10 and Top 5 Players Market Share by Antimicrobial Peptides Sales in 2020
    Figure 28. The Top 10 and Top 5 Players Market Share by Antimicrobial Peptides Revenue in 2020
    Figure 29. Antimicrobial Peptides Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
    Figure 30. Global Antimicrobial Peptides Sales Market Share by Type (2016-2027)
    Figure 31. Global Antimicrobial Peptides Revenue Market Share by Type (2016-2027)
    Figure 32. Global Antimicrobial Peptides Sales Market Share by Application (2016-2027)
    Figure 33. Global Antimicrobial Peptides Revenue Market Share by Application (2016-2027)
    Figure 34. North America Antimicrobial Peptides Sales Market Share by Type (2016-2027)
    Figure 35. North America Antimicrobial Peptides Revenue Market Share by Type (2016-2027)
    Figure 36. North America Antimicrobial Peptides Sales Market Share by Application (2016-2027)
    Figure 37. North America Antimicrobial Peptides Revenue Market Share by Application (2016-2027)
    Figure 38. North America Antimicrobial Peptides Sales Share by Country (2016-2027)
    Figure 39. North America Antimicrobial Peptides Revenue Share by Country (2016-2027)
    Figure 40. U.S. Antimicrobial Peptides Revenue (2016-2027) & (US$ Million)
    Figure 41. Canada Antimicrobial Peptides Revenue (2016-2027) & (US$ Million)
    Figure 42. Europe Antimicrobial Peptides Sales Market Share by Type (2016-2027)
    Figure 43. Europe Antimicrobial Peptides Revenue Market Share by Type (2016-2027)
    Figure 44. Europe Antimicrobial Peptides Sales Market Share by Application (2016-2027)
    Figure 45. Europe Antimicrobial Peptides Revenue Market Share by Application (2016-2027)
    Figure 46. Europe Antimicrobial Peptides Sales Share by Country (2016-2027)
    Figure 47. Europe Antimicrobial Peptides Revenue Share by Country (2016-2027)
    Figure 48. Germany Antimicrobial Peptides Revenue (2016-2027) & (US$ Million)
    Figure 49. France Antimicrobial Peptides Revenue (2016-2027) & (US$ Million)
    Figure 50. U.K. Antimicrobial Peptides Revenue (2016-2027) & (US$ Million)
    Figure 51. Italy Antimicrobial Peptides Revenue (2016-2027) & (US$ Million)
    Figure 52. Russia Antimicrobial Peptides Revenue (2016-2027) & (US$ Million)
    Figure 53. Asia Pacific Antimicrobial Peptides Sales Market Share by Type (2016-2027)
    Figure 54. Asia Pacific Antimicrobial Peptides Revenue Market Share by Type (2016-2027)
    Figure 55. Asia Pacific Antimicrobial Peptides Sales Market Share by Application (2016-2027)
    Figure 56. Asia Pacific Antimicrobial Peptides Revenue Market Share by Application (2016-2027)
    Figure 57. Asia Pacific Antimicrobial Peptides Sales Share by Region (2016-2027)
    Figure 58. Asia Pacific Antimicrobial Peptides Revenue Share by Region (2016-2027)
    Figure 59. China Antimicrobial Peptides Revenue (2016-2027) & (US$ Million)
    Figure 60. Japan Antimicrobial Peptides Revenue (2016-2027) & (US$ Million)
    Figure 61. South Korea Antimicrobial Peptides Revenue (2016-2027) & (US$ Million)
    Figure 62. India Antimicrobial Peptides Revenue (2016-2027) & (US$ Million)
    Figure 63. Australia Antimicrobial Peptides Revenue (2016-2027) & (US$ Million)
    Figure 64. Taiwan Antimicrobial Peptides Revenue (2016-2027) & (US$ Million)
    Figure 65. Indonesia Antimicrobial Peptides Revenue (2016-2027) & (US$ Million)
    Figure 66. Thailand Antimicrobial Peptides Revenue (2016-2027) & (US$ Million)
    Figure 67. Malaysia Antimicrobial Peptides Revenue (2016-2027) & (US$ Million)
    Figure 68. Philippines Antimicrobial Peptides Revenue (2016-2027) & (US$ Million)
    Figure 69. Latin America Antimicrobial Peptides Sales Market Share by Type (2016-2027)
    Figure 70. Latin America Antimicrobial Peptides Revenue Market Share by Type (2016-2027)
    Figure 71. Latin America Antimicrobial Peptides Sales Market Share by Application (2016-2027)
    Figure 72. Latin America Antimicrobial Peptides Revenue Market Share by Application (2016-2027)
    Figure 73. Latin America Antimicrobial Peptides Sales Share by Country (2016-2027)
    Figure 74. Latin America Antimicrobial Peptides Revenue Share by Country (2016-2027)
    Figure 75. Mexico Antimicrobial Peptides Revenue (2016-2027) & (US$ Million)
    Figure 76. Brazil Antimicrobial Peptides Revenue (2016-2027) & (US$ Million)
    Figure 77. Argentina Antimicrobial Peptides Revenue (2016-2027) & (US$ Million)
    Figure 78. Middle East and Africa Antimicrobial Peptides Sales Market Share by Type (2016-2027)
    Figure 79. Middle East and Africa Antimicrobial Peptides Revenue Market Share by Type (2016-2027)
    Figure 80. Middle East and Africa Antimicrobial Peptides Sales Market Share by Application (2016-2027)
    Figure 81. Middle East and Africa Antimicrobial Peptides Revenue Market Share by Application (2016-2027)
    Figure 82. Middle East and Africa Antimicrobial Peptides Sales Share by Country (2016-2027)
    Figure 83. Middle East and Africa Antimicrobial Peptides Revenue Share by Country (2016-2027)
    Figure 84. Turkey Antimicrobial Peptides Revenue (2016-2027) & (US$ Million)
    Figure 85. Saudi Arabia Antimicrobial Peptides Revenue (2016-2027) & (US$ Million)
    Figure 86. U.A.E Antimicrobial Peptides Revenue (2016-2027) & (US$ Million)
    Figure 87. Antimicrobial Peptides Value Chain
    Figure 88. Antimicrobial Peptides Production Process
    Figure 89. Channels of Distribution
    Figure 90. Distributors Profiles
    Figure 91. Bottom-up and Top-down Approaches for This Report
    Figure 92. Data Triangulation
    Figure 93. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
AnaSpec
AMP Biotech
Phoenix Biotech
Novabiotics
Chinese Peptide
Ontores
GenScript
Hycult Biotech
Sunsmile
Ruixing Biotechnology
Zhongnong Yingtai Biotechnology
Glam Technology
ProteLight Pharmaceutical & Biotechnology
Frequently Asked Questions
Antimicrobial Peptides report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Antimicrobial Peptides report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Antimicrobial Peptides report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports